zaltrap 200mg8ml concentrate for solution for infusion vials
sanofi - aflibercept - solution for infusion - 25mg/1ml
zaltrap
sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.
zaltrap 25 mg/ml 1 vial solució perfussió 4 ml
zaltrap 25 mg/ml 1 vial solució perfussió 8 ml
zaltrap solution
sanofi-aventis canada inc - aflibercept - solution - 100mg - aflibercept 100mg - antineoplastic agents
zaltrap solution
sanofi-aventis canada inc - aflibercept - solution - 200mg - aflibercept 200mg - antineoplastic agents
zaltrap 25mgml concentrate for solution for infusion
sanofi-aventis (malaysia) sdn. bhd. - aflibercept -
salapin - salbutamol syrup oral solution 2mg/5ml
pinewood laboratories limited - salbutamol - oral solution - salbutamol 2 mg/5ml - drugs for obstructive airway diseases
zaltrap concentrate for solution for infusion 25 mg/ml
bahrain pharmacy - aflibercept - concentrate for solution for infusion - 25
zaltrap concentrate for solution for infusion 25 mg/ml
bahrain pharmacy - aflibercept - concentrate for solution for infusion - 25